Bio-Rad Laboratories BIO
NYSE BIO
$376.85 -3.27 (-0.86%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Net Margin Growth (3y) (2012 - 2026)

Analysis

Bio-Rad Laboratories (BIO) Net Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Thermo Fisher Scientific 225.48 Bn 221.41 Bn 8.34 Bn 191.00
2 Danaher 144.42 Bn 140.08 Bn 3.61 Bn -482.00
3 Agilent Technologies 40.86 Bn 39.11 Bn 1.04 Bn 1,264.00
4 Illumina 30.97 Bn 29.80 Bn 770.00 Mn 3,776.00
5 Revvity 13.85 Bn 12.83 Bn 416.87 Mn 209.00
6 Bio-Techne 11.27 Bn 11.01 Bn 211.39 Mn 184.00
7 Bio-Rad Laboratories 10.11 Bn 8.49 Bn 345.80 Mn 22,769.00
8 Repligen 9.33 Bn 8.31 Bn 110.04 Mn -998.00
9 10x Genomics 8.77 Bn 8.21 Bn 112.50 Mn 3,064.00
10 Bruker 8.30 Bn 8.09 Bn 416.00 Mn -1,588.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22,769.00
Mar 31, 2026 -9,921.00
Dec 31, 2025 -949.00
Sep 30, 2025 -2,844.00
Jun 30, 2025 18,263.00
Mar 31, 2025 49,191.00
Dec 31, 2024 10,636.00
Sep 30, 2024 -42,530.00
Jun 30, 2024 -46,685.00
Mar 31, 2024 -7,163.00
Dec 31, 2023 -5,591.00
Sep 30, 2023 -18,632.00
Jun 30, 2023 -35,064.00
Mar 31, 2023 -10,981.00
Dec 31, 2022 2,473.00
Sep 30, 2022 2,225.00
Jun 30, 2022 -23,844.00
Mar 31, 2022 -63,716.00
Dec 31, 2021 -7,930.00
Sep 30, 2021 47,643.00